Titre : JNK Mitogen-Activated Protein Kinases

JNK Mitogen-Activated Protein Kinases : Questions médicales fréquentes

Termes MeSH sélectionnés :

Trigeminal Nerve

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une activation des JNK ?

Des tests de signalisation cellulaire et des analyses protéomiques peuvent être utilisés.
Kinases Signalisation cellulaire
#2

Quels biomarqueurs indiquent l'activation des JNK ?

Des niveaux élevés de protéines phosphorylées c-Jun peuvent indiquer une activation.
Biomarqueurs Phosphorylation
#3

Les tests génétiques sont-ils utiles pour les JNK ?

Oui, des tests peuvent identifier des mutations affectant la voie JNK.
Tests génétiques Mutations
#4

Quels examens d'imagerie sont utilisés pour les JNK ?

L'imagerie par résonance magnétique peut aider à visualiser des effets cellulaires.
Imagerie par résonance magnétique Effets cellulaires
#5

Peut-on mesurer l'activité des JNK dans le sang ?

Des échantillons sanguins peuvent être analysés pour des marqueurs d'activation.
Échantillons sanguins Marqueurs d'activation

Symptômes 5

#1

Quels symptômes sont liés à l'activation des JNK ?

L'activation peut entraîner inflammation, apoptose et dysfonction cellulaire.
Inflammation Apoptose
#2

Les JNK sont-ils impliqués dans des maladies ?

Oui, ils sont associés à des maladies comme le cancer et les maladies neurodégénératives.
Cancer Maladies neurodégénératives
#3

Comment les JNK affectent-ils la douleur ?

Ils modulent la signalisation de la douleur, contribuant à des douleurs chroniques.
Douleur Signalisation
#4

Les JNK influencent-ils le métabolisme ?

Oui, ils jouent un rôle dans la régulation du métabolisme énergétique.
Métabolisme Régulation
#5

Y a-t-il des symptômes neurologiques associés aux JNK ?

Des troubles cognitifs et des troubles de l'humeur peuvent être observés.
Troubles cognitifs Troubles de l'humeur

Prévention 5

#1

Comment prévenir l'activation des JNK ?

Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut aider.
Mode de vie sain Alimentation équilibrée
#2

Le stress influence-t-il les JNK ?

Oui, le stress oxydatif peut activer les JNK, donc la gestion du stress est cruciale.
Stress oxydatif Gestion du stress
#3

Les antioxydants aident-ils à prévenir l'activation des JNK ?

Oui, les antioxydants peuvent réduire le stress oxydatif et l'activation des JNK.
Antioxydants Stress oxydatif
#4

L'exercice physique prévient-il l'activation des JNK ?

Oui, l'exercice régulier peut moduler positivement l'activité des JNK.
Exercice physique Modulation
#5

Les habitudes alimentaires influencent-elles les JNK ?

Une alimentation riche en nutriments peut réduire l'activation des JNK.
Habitudes alimentaires Nutriments

Traitements 5

#1

Quels traitements ciblent les JNK ?

Des inhibiteurs spécifiques des JNK sont en développement pour diverses maladies.
Inhibiteurs Développement thérapeutique
#2

Les anti-inflammatoires affectent-ils les JNK ?

Oui, certains anti-inflammatoires peuvent moduler l'activité des JNK.
Anti-inflammatoires Modulation
#3

La thérapie génique peut-elle cibler les JNK ?

La thérapie génique est explorée pour corriger des dysfonctionnements des JNK.
Thérapie génique Dysfonctionnements
#4

Les traitements naturels influencent-ils les JNK ?

Certaines plantes médicinales peuvent avoir un effet sur l'activation des JNK.
Plantes médicinales Activation
#5

Les traitements anticancéreux ciblent-ils les JNK ?

Oui, des traitements anticancéreux visent à inhiber les voies JNK dans les cellules tumorales.
Traitements anticancéreux Cellules tumorales

Complications 5

#1

Quelles complications sont liées à l'activation des JNK ?

L'activation excessive des JNK peut entraîner des maladies inflammatoires et cancéreuses.
Maladies inflammatoires Cancer
#2

Les JNK sont-ils liés à des complications cardiovasculaires ?

Oui, l'activation des JNK est associée à des maladies cardiovasculaires.
Complications cardiovasculaires Maladies cardiovasculaires
#3

Les JNK influencent-ils le vieillissement cellulaire ?

Oui, une activation prolongée des JNK peut accélérer le vieillissement cellulaire.
Vieillissement cellulaire Activation prolongée
#4

Y a-t-il des complications neurologiques liées aux JNK ?

Oui, l'activation des JNK est impliquée dans des troubles neurodégénératifs.
Troubles neurodégénératifs Activation
#5

Les JNK sont-ils impliqués dans des complications métaboliques ?

Oui, ils sont liés à des troubles métaboliques comme le diabète.
Troubles métaboliques Diabète

Facteurs de risque 5

#1

Quels facteurs de risque influencent les JNK ?

Le stress, l'inflammation chronique et l'obésité sont des facteurs de risque connus.
Stress Inflammation chronique
#2

L'alimentation affecte-t-elle les JNK ?

Oui, une alimentation riche en graisses saturées peut augmenter l'activation des JNK.
Alimentation Graisses saturées
#3

Le tabagisme influence-t-il les JNK ?

Oui, le tabagisme est un facteur de risque qui peut activer les JNK.
Tabagisme Facteurs de risque
#4

L'exposition à des toxines affecte-t-elle les JNK ?

Oui, l'exposition à des toxines environnementales peut activer les JNK.
Toxines environnementales Activation
#5

Le manque d'exercice est-il un facteur de risque pour les JNK ?

Oui, un mode de vie sédentaire peut augmenter le risque d'activation des JNK.
Mode de vie sédentaire Facteurs de risque
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "JNK Mitogen-Activated Protein Kinases : Questions médicales les plus fréquentes", "headline": "JNK Mitogen-Activated Protein Kinases : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les JNK Mitogen-Activated Protein Kinases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-10", "dateModified": "2025-05-05", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "JNK Mitogen-Activated Protein Kinases" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Mitogen-Activated Protein Kinases", "url": "https://questionsmedicales.fr/mesh/D020928", "about": { "@type": "MedicalCondition", "name": "Mitogen-Activated Protein Kinases", "code": { "@type": "MedicalCode", "code": "D020928", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.476.563.567" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mitogen-Activated Protein Kinase 8", "alternateName": "Mitogen-Activated Protein Kinase 8", "url": "https://questionsmedicales.fr/mesh/D048055", "about": { "@type": "MedicalCondition", "name": "Mitogen-Activated Protein Kinase 8", "code": { "@type": "MedicalCode", "code": "D048055", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.476.563.567.374.500" } } }, { "@type": "MedicalWebPage", "name": "Mitogen-Activated Protein Kinase 9", "alternateName": "Mitogen-Activated Protein Kinase 9", "url": "https://questionsmedicales.fr/mesh/D048056", "about": { "@type": "MedicalCondition", "name": "Mitogen-Activated Protein Kinase 9", "code": { "@type": "MedicalCode", "code": "D048056", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.476.563.567.374.750" } } }, { "@type": "MedicalWebPage", "name": "Mitogen-Activated Protein Kinase 10", "alternateName": "Mitogen-Activated Protein Kinase 10", "url": "https://questionsmedicales.fr/mesh/D048057", "about": { "@type": "MedicalCondition", "name": "Mitogen-Activated Protein Kinase 10", "code": { "@type": "MedicalCode", "code": "D048057", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.476.563.567.374.800" } } } ], "about": { "@type": "MedicalCondition", "name": "JNK Mitogen-Activated Protein Kinases", "alternateName": "JNK Mitogen-Activated Protein Kinases", "code": { "@type": "MedicalCode", "code": "D048031", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Mohammad Shafiq", "url": "https://questionsmedicales.fr/author/Mohammad%20Shafiq", "affiliation": { "@type": "Organization", "name": "From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India." } }, { "@type": "Person", "name": "Kumaravelu Jagavelu", "url": "https://questionsmedicales.fr/author/Kumaravelu%20Jagavelu", "affiliation": { "@type": "Organization", "name": "From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India." } }, { "@type": "Person", "name": "Neeraj Kumar Verma", "url": "https://questionsmedicales.fr/author/Neeraj%20Kumar%20Verma", "affiliation": { "@type": "Organization", "name": "Division of Molecular and Structural Biology (N.K.V., J.K.G.), CSIR-Central Drug Research Institute, Lucknow, India." } }, { "@type": "Person", "name": "Jimut Kanti Ghosh", "url": "https://questionsmedicales.fr/author/Jimut%20Kanti%20Ghosh", "affiliation": { "@type": "Organization", "name": "Division of Molecular and Structural Biology (N.K.V., J.K.G.), CSIR-Central Drug Research Institute, Lucknow, India." } }, { "@type": "Person", "name": "Matthias Gaestel", "url": "https://questionsmedicales.fr/author/Matthias%20Gaestel", "affiliation": { "@type": "Organization", "name": "Institute for Zellbiochemie, Medizinische Hochschule Hannover (MHH), Hanover, Germany (M.G.)." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Correlation study between multiplanar reconstruction trigeminal nerve angulation and trigeminal neuralgia.", "datePublished": "2022-10-12", "url": "https://questionsmedicales.fr/article/36224533", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12883-022-02906-9" } }, { "@type": "ScholarlyArticle", "name": "Postoperative trigeminal neuropathy outcomes following surgery for tumors involving the trigeminal nerve.", "datePublished": "2023-08-15", "url": "https://questionsmedicales.fr/article/37581723", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00701-023-05735-y" } }, { "@type": "ScholarlyArticle", "name": "Application of Sequential Thresholding-Based Automated Reconstruction of the Trigeminal Nerve in Trigeminal Neuralgia.", "datePublished": "2023-10-27", "url": "https://questionsmedicales.fr/article/37890771", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.wneu.2023.10.095" } }, { "@type": "ScholarlyArticle", "name": "Diffusion tensor and kurtosis imaging reveal microstructural changes in the trigeminal nerves of patients with trigeminal neuralgia.", "datePublished": "2023-05-31", "url": "https://questionsmedicales.fr/article/37256350", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00330-023-09762-2" } }, { "@type": "ScholarlyArticle", "name": "Gamma Knife Radiosurgery Targeting the Trigeminal Nerve for Tumor-Related Trigeminal Neuralgia: A Case Series.", "datePublished": "2023-04-03", "url": "https://questionsmedicales.fr/article/37019305", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.wneu.2023.03.113" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines et peptides de signalisation intracellulaire", "item": "https://questionsmedicales.fr/mesh/D047908" }, { "@type": "ListItem", "position": 5, "name": "Protein-Serine-Threonine Kinases", "item": "https://questionsmedicales.fr/mesh/D017346" }, { "@type": "ListItem", "position": 6, "name": "Mitogen-Activated Protein Kinases", "item": "https://questionsmedicales.fr/mesh/D020928" }, { "@type": "ListItem", "position": 7, "name": "JNK Mitogen-Activated Protein Kinases", "item": "https://questionsmedicales.fr/mesh/D048031" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : JNK Mitogen-Activated Protein Kinases - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur JNK Mitogen-Activated Protein Kinases", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur JNK Mitogen-Activated Protein Kinases", "description": "Comment diagnostiquer une activation des JNK ?\nQuels biomarqueurs indiquent l'activation des JNK ?\nLes tests génétiques sont-ils utiles pour les JNK ?\nQuels examens d'imagerie sont utilisés pour les JNK ?\nPeut-on mesurer l'activité des JNK dans le sang ?", "url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Trigeminal+Nerve#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur JNK Mitogen-Activated Protein Kinases", "description": "Quels symptômes sont liés à l'activation des JNK ?\nLes JNK sont-ils impliqués dans des maladies ?\nComment les JNK affectent-ils la douleur ?\nLes JNK influencent-ils le métabolisme ?\nY a-t-il des symptômes neurologiques associés aux JNK ?", "url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Trigeminal+Nerve#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur JNK Mitogen-Activated Protein Kinases", "description": "Comment prévenir l'activation des JNK ?\nLe stress influence-t-il les JNK ?\nLes antioxydants aident-ils à prévenir l'activation des JNK ?\nL'exercice physique prévient-il l'activation des JNK ?\nLes habitudes alimentaires influencent-elles les JNK ?", "url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Trigeminal+Nerve#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur JNK Mitogen-Activated Protein Kinases", "description": "Quels traitements ciblent les JNK ?\nLes anti-inflammatoires affectent-ils les JNK ?\nLa thérapie génique peut-elle cibler les JNK ?\nLes traitements naturels influencent-ils les JNK ?\nLes traitements anticancéreux ciblent-ils les JNK ?", "url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Trigeminal+Nerve#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur JNK Mitogen-Activated Protein Kinases", "description": "Quelles complications sont liées à l'activation des JNK ?\nLes JNK sont-ils liés à des complications cardiovasculaires ?\nLes JNK influencent-ils le vieillissement cellulaire ?\nY a-t-il des complications neurologiques liées aux JNK ?\nLes JNK sont-ils impliqués dans des complications métaboliques ?", "url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Trigeminal+Nerve#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur JNK Mitogen-Activated Protein Kinases", "description": "Quels facteurs de risque influencent les JNK ?\nL'alimentation affecte-t-elle les JNK ?\nLe tabagisme influence-t-il les JNK ?\nL'exposition à des toxines affecte-t-elle les JNK ?\nLe manque d'exercice est-il un facteur de risque pour les JNK ?", "url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Trigeminal+Nerve#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une activation des JNK ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de signalisation cellulaire et des analyses protéomiques peuvent être utilisés." } }, { "@type": "Question", "name": "Quels biomarqueurs indiquent l'activation des JNK ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux élevés de protéines phosphorylées c-Jun peuvent indiquer une activation." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles pour les JNK ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests peuvent identifier des mutations affectant la voie JNK." } }, { "@type": "Question", "name": "Quels examens d'imagerie sont utilisés pour les JNK ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie par résonance magnétique peut aider à visualiser des effets cellulaires." } }, { "@type": "Question", "name": "Peut-on mesurer l'activité des JNK dans le sang ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des échantillons sanguins peuvent être analysés pour des marqueurs d'activation." } }, { "@type": "Question", "name": "Quels symptômes sont liés à l'activation des JNK ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "L'activation peut entraîner inflammation, apoptose et dysfonction cellulaire." } }, { "@type": "Question", "name": "Les JNK sont-ils impliqués dans des maladies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont associés à des maladies comme le cancer et les maladies neurodégénératives." } }, { "@type": "Question", "name": "Comment les JNK affectent-ils la douleur ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils modulent la signalisation de la douleur, contribuant à des douleurs chroniques." } }, { "@type": "Question", "name": "Les JNK influencent-ils le métabolisme ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils jouent un rôle dans la régulation du métabolisme énergétique." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés aux JNK ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles cognitifs et des troubles de l'humeur peuvent être observés." } }, { "@type": "Question", "name": "Comment prévenir l'activation des JNK ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut aider." } }, { "@type": "Question", "name": "Le stress influence-t-il les JNK ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress oxydatif peut activer les JNK, donc la gestion du stress est cruciale." } }, { "@type": "Question", "name": "Les antioxydants aident-ils à prévenir l'activation des JNK ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antioxydants peuvent réduire le stress oxydatif et l'activation des JNK." } }, { "@type": "Question", "name": "L'exercice physique prévient-il l'activation des JNK ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut moduler positivement l'activité des JNK." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles les JNK ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en nutriments peut réduire l'activation des JNK." } }, { "@type": "Question", "name": "Quels traitements ciblent les JNK ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des inhibiteurs spécifiques des JNK sont en développement pour diverses maladies." } }, { "@type": "Question", "name": "Les anti-inflammatoires affectent-ils les JNK ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains anti-inflammatoires peuvent moduler l'activité des JNK." } }, { "@type": "Question", "name": "La thérapie génique peut-elle cibler les JNK ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est explorée pour corriger des dysfonctionnements des JNK." } }, { "@type": "Question", "name": "Les traitements naturels influencent-ils les JNK ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certaines plantes médicinales peuvent avoir un effet sur l'activation des JNK." } }, { "@type": "Question", "name": "Les traitements anticancéreux ciblent-ils les JNK ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements anticancéreux visent à inhiber les voies JNK dans les cellules tumorales." } }, { "@type": "Question", "name": "Quelles complications sont liées à l'activation des JNK ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "L'activation excessive des JNK peut entraîner des maladies inflammatoires et cancéreuses." } }, { "@type": "Question", "name": "Les JNK sont-ils liés à des complications cardiovasculaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'activation des JNK est associée à des maladies cardiovasculaires." } }, { "@type": "Question", "name": "Les JNK influencent-ils le vieillissement cellulaire ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une activation prolongée des JNK peut accélérer le vieillissement cellulaire." } }, { "@type": "Question", "name": "Y a-t-il des complications neurologiques liées aux JNK ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'activation des JNK est impliquée dans des troubles neurodégénératifs." } }, { "@type": "Question", "name": "Les JNK sont-ils impliqués dans des complications métaboliques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont liés à des troubles métaboliques comme le diabète." } }, { "@type": "Question", "name": "Quels facteurs de risque influencent les JNK ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Le stress, l'inflammation chronique et l'obésité sont des facteurs de risque connus." } }, { "@type": "Question", "name": "L'alimentation affecte-t-elle les JNK ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses saturées peut augmenter l'activation des JNK." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il les JNK ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est un facteur de risque qui peut activer les JNK." } }, { "@type": "Question", "name": "L'exposition à des toxines affecte-t-elle les JNK ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines environnementales peut activer les JNK." } }, { "@type": "Question", "name": "Le manque d'exercice est-il un facteur de risque pour les JNK ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire peut augmenter le risque d'activation des JNK." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 05/05/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Mohammad Shafiq

2 publications dans cette catégorie

Affiliations :
  • From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India.
  • Academy of Scientific and Innovative Research, Ghaziabad, India (M.S., K.J., K.H.).

Kumaravelu Jagavelu

2 publications dans cette catégorie

Affiliations :
  • From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India.
  • Academy of Scientific and Innovative Research, Ghaziabad, India (M.S., K.J., K.H.).

Neeraj Kumar Verma

2 publications dans cette catégorie

Affiliations :
  • Division of Molecular and Structural Biology (N.K.V., J.K.G.), CSIR-Central Drug Research Institute, Lucknow, India.

Jimut Kanti Ghosh

2 publications dans cette catégorie

Affiliations :
  • Division of Molecular and Structural Biology (N.K.V., J.K.G.), CSIR-Central Drug Research Institute, Lucknow, India.

Matthias Gaestel

2 publications dans cette catégorie

Affiliations :
  • Institute for Zellbiochemie, Medizinische Hochschule Hannover (MHH), Hanover, Germany (M.G.).

Kashif Hanif

2 publications dans cette catégorie

Affiliations :
  • From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India.
  • Academy of Scientific and Innovative Research, Ghaziabad, India (M.S., K.J., K.H.).

Mingyi Jiang

2 publications dans cette catégorie

Affiliations :
  • College of Life Sciences and National Key Laboratory of Crop Genetics and Germplasm Enhancement, Nanjing Agricultural University, Nanjing 210095, China.

Yu Liu

2 publications dans cette catégorie

Affiliations :
  • Department of Radiology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, Hubei, China.

Gisele Picolo

2 publications dans cette catégorie

Affiliations :
  • Laboratório Especial de Dor e Sinalização, Instituto Butantan, São Paulo, Brazil.

Yara Cury

2 publications dans cette catégorie

Affiliations :
  • Laboratório Especial de Dor e Sinalização, Instituto Butantan, São Paulo, Brazil.

Vanessa O Zambelli

2 publications dans cette catégorie

Affiliations :
  • Laboratório Especial de Dor e Sinalização, Instituto Butantan, São Paulo, Brazil.

Minchae Kim

1 publication dans cette catégorie

Affiliations :
  • Department of Life Science (BK21 program), Chung-Ang University, Seoul, South Korea.
Publications dans "JNK Mitogen-Activated Protein Kinases" :

Soongon Jeong

1 publication dans cette catégorie

Affiliations :
  • Department of Life Science (BK21 program), Chung-Ang University, Seoul, South Korea.
Publications dans "JNK Mitogen-Activated Protein Kinases" :

Chae Woo Lim

1 publication dans cette catégorie

Affiliations :
  • Department of Life Science (BK21 program), Chung-Ang University, Seoul, South Korea.
Publications dans "JNK Mitogen-Activated Protein Kinases" :

Sung Chul Lee

1 publication dans cette catégorie

Affiliations :
  • Department of Life Science (BK21 program), Chung-Ang University, Seoul, South Korea.
Publications dans "JNK Mitogen-Activated Protein Kinases" :

Tayeb Muhammad

1 publication dans cette catégorie

Affiliations :
  • College of Horticulture, Northwest A&F University, Yangling 712100, China. tayebmuhammad@nwsuaf.edu.cn.
  • State Key Laboratory of Crop Stress Biology in Arid Regions, Northwest A&F University, Yangling 712100, China. tayebmuhammad@nwsuaf.edu.cn.
Publications dans "JNK Mitogen-Activated Protein Kinases" :

Jie Zhang

1 publication dans cette catégorie

Affiliations :
  • College of Horticulture, Northwest A&F University, Yangling 712100, China. 15591858981@163.com.
  • State Key Laboratory of Crop Stress Biology in Arid Regions, Northwest A&F University, Yangling 712100, China. 15591858981@163.com.
Publications dans "JNK Mitogen-Activated Protein Kinases" :

Yalin Ma

1 publication dans cette catégorie

Affiliations :
  • College of Horticulture, Northwest A&F University, Yangling 712100, China. 15891785931@163.com.
  • State Key Laboratory of Crop Stress Biology in Arid Regions, Northwest A&F University, Yangling 712100, China. 15891785931@163.com.
Publications dans "JNK Mitogen-Activated Protein Kinases" :

Yushun Li

1 publication dans cette catégorie

Affiliations :
  • College of Horticulture, Northwest A&F University, Yangling 712100, China. liyushunaf@163.com.
  • State Key Laboratory of Crop Stress Biology in Arid Regions, Northwest A&F University, Yangling 712100, China. liyushunaf@163.com.
Publications dans "JNK Mitogen-Activated Protein Kinases" :

Fei Zhang

1 publication dans cette catégorie

Affiliations :
  • College of Horticulture, Northwest A&F University, Yangling 712100, China. feizhang@nwsuaf.edu.cn.
Publications dans "JNK Mitogen-Activated Protein Kinases" :

Sources (9250 au total)

Correlation study between multiplanar reconstruction trigeminal nerve angulation and trigeminal neuralgia.

Neurovascular compression (NVC) produces morphological changes on the trigeminal nerve root is considered the cause of trigeminal neuralgia (TN), but there were some patients with TN found no NVC, and... Patients with classical symptoms of TN were recruited as observation group (OG) in this study, 50 healthy controls were enrolled as control group (CG), the OG was further subtyped into young patients ... Ultimately, 95 patients with primary TN were recruited in OG, aged from 25 to 84 (61.15 ± 12.70) years with a course of 0.5 to 30 (5.03 ± 5.41) years, their onset age ranged from 24 to 82 (56.13 ± 11.... This study suggested that TNA might play a role in TN, small TNA could be a risk factor of TN. Furthermore, patients with small TNA are more likely to combine with TM, but more studies are needed to e...

Postoperative trigeminal neuropathy outcomes following surgery for tumors involving the trigeminal nerve.

To observe the evolution and outcomes of postoperative trigeminal neuropathy following surgery of tumor involving the trigeminal nerve.... A prospective observational study was conducted between October 2018 and February 2019 involving 25 patients with tumors confirmed to involve the trigeminal nerve during surgery by senior author. Pre-... This study included 18 cases of meningioma and seven of trigeminal schwannoma. Among the meningioma cases, 55.6% of the patients reported facial sensory dysfunction before surgery, 33.3% presented ocu... Postoperative trigeminal neuropathy is a common complication with a high incidence rate and poor recovery outcomes after surgery for tumors involving the trigeminal nerve. When trigeminal nerve damage...

Application of Sequential Thresholding-Based Automated Reconstruction of the Trigeminal Nerve in Trigeminal Neuralgia.

High-resolution magnetic resonance imaging (MRI) of the trigeminal nerve is indispensable for workup of trigeminal neuralgia (TN) before microvascular decompression; however, the evaluation is often s... A total of 42 patients with TN who underwent high-resolution MRI before microvascular decompression in 2022 were included in our study. Segmentation of the trigeminal nerve and contacting structures w... Of the 42 patients, 32 (76.2%) were found to show neurovascular conflict based solely on their STAR-TN segmentations and 10 (23.8%) were found to not show neurovascular conflict. Compared with the int... STAR-TN allows for 3-dimensional visualization and identification of neurovascular conflict with improved sensitivity compared with neuroradiologist assessments from MRI slices....

Diffusion tensor and kurtosis imaging reveal microstructural changes in the trigeminal nerves of patients with trigeminal neuralgia.

To evaluate the use of diffusion tensor imaging (DTI) and diffusion kurtosis imaging (DKI) for detection of microstructural changes in the trigeminal nerves of trigeminal neuralgia (TN) patients.... Forty TN patients and 40 healthy controls were examined using 3 T magnetic resonance imaging (MRI) to evaluate DTI and DKI parameters in trigeminal nerves. One-way ANOVA was used to test the differenc... Compared to the unaffected sides and controls, the FA, MK, and Kr of the affected sides of TN patients were significantly reduced, while ADC was significantly increased (p < 0.05). The diagnostic effi... DTI and DKI allowed detection of microstructural changes in TN-affected trigeminal nerves. FA DR was the best independent predictor of microstructural changes in TN.... Both DTI and DKI can be used for noninvasive quantitative evaluation of the changes in the microstructure of the cisternal segment of the cranial nerves in clinical practice.... • Diffusion tensor imaging (DTI) can be used to evaluate the in vivo integrity of white matter and nerve fiber pathway. • Diffusion kurtosis imaging (DKI) has been shown to be considerable sensitive t...

Gamma Knife Radiosurgery Targeting the Trigeminal Nerve for Tumor-Related Trigeminal Neuralgia: A Case Series.

Tumor-related trigeminal neuralgia (TN) is a challenging condition to manage that is commonly treated by surgical resection of the tumor. Stereotactic radiosurgery targeting the tumor is used to contr... A retrospective review of our GKRS database identified 6 patients with unilateral tumor-related TN treated with GKRS targeting the trigeminal nerve between 2014 and 2020. Five patients had undergone p... Three patients achieved a Barrow Neurological Institute score of IIIb or better, indicating pain reduction, within a mean period of 4.3 months after GKRS. The maximum dose for GKRS ranged from 80 to 8... GKRS targeting the trigeminal nerve could be a safe and effective treatment for a subset of patients with tumor-related TN who are unsuitable for surgical removal of the tumor or whose pain is refract...

Morphometric examination of trigeminal nerve and its adjacent structures in patients with trigeminal neuralgia: a case-control study.

Morphological differences that can lead the trigeminal nerve to neurovascular conflict and a new solitary pontine lesion are associated with the pathogenesis of trigeminal neuralgia (TN). In this case... This study included 25 patients with TN followed up for pain in the Department of Algology, Faculty of Medicine, and 25 age- and gender-matched controls. We performed morphometric measurements includi... In patients with TN, on the affected side, length and volume of the trigeminal nerve and cerebellopontine cistern volume were found smaller than controls (p < 0.05). Pons volume was higher in patients... The cerebellopontine cistern volume has a significant impact on the morphometric characteristics of the trigeminal nerve. Especially, whether the increase in the volume of pons causes a decrease in th...

Multiple Vessel Compression of the Trigeminal Nerve Is Associated With Worse Outcomes in Trigeminal Neuralgia After Microvascular Decompression.

Whether the total number of compressive vessels in trigeminal neuralgia (TN) affects outcomes after microvascular decompression (MVD) is unknown.... To investigate whether the number of compressive vessels is associated with outcomes after MVD.... We retrospectively reviewed all patients with TN who underwent MVDs at our institution from 2007 to 2020. The number and identity of compressive vessels on the trigeminal nerve were recorded. Preopera... We identified 496 patients with a single vessel and 381 patients with multiple vessels compressing the trigeminal nerve. Compared with patients with a single compressive vessel, patients with multiple... TN patients with a single compressive vessel exhibited better pain outcomes after an MVD. Patients with multiple compressive vessels exhibited higher pain scores preoperatively and incurred a higher r...

MRI Findings in Trigeminal Neuralgia without Neurovascular Compression: Implications of Petrous Ridge and Trigeminal Nerve Angles.

To determine the anatomical characteristics of the petrous ridge and trigeminal nerve in trigeminal neuralgia (TN) without neurovascular compression (NVC).... From May 2017 to March 2021, 66 patients (49 female and 17 male; mean age ± standard deviation [SD], 56.8 ± 13.3 years) with TN without NVC and 57 controls (46 female and 11 male; 52.0 ± 15.6 years) w... In TN patients without NVC, the mean ± standard deviation (SD) of APR on the symptomatic side (98.40° ± 19.75°) was significantly smaller than that of the asymptomatic side (105.59° ± 22.45°,... In patients with TN without NVC, APR and ATN were smaller than those in controls, which may explain the potential cause of TN and provide additional information for diagnosis....

Sagittal Angle of the Trigeminal Nerve at the Porus Trigeminus: A Novel Measurement to Distinguish Different Causes of Classic Trigeminal Neuralgia.

Classic trigeminal neuralgia is a clinical syndrome of facial pain, most often attributable to vascular compression of the proximal cisternal segment of the trigeminal nerve and treatable with microva... We retrospectively identified patients with either classic trigeminal neuralgia (... Control patients had a mean SATNaPT of 170° (SD, 11°) with a normal distribution. The contralateral asymptomatic nerve in patients with classic trigeminal neuralgia had the same distribution of angles... Patients with the clinical syndrome of classic trigeminal neuralgia fell into 2 categories based on the radiologic measurement of the SATNaPT. Most patients had an anatomically normal nerve that was a...

Trigeminal Nerve Involvement in Bulbar-Onset Anti-IgLON5 Disease.

Anti-IgLON5 disease (IgLON5-D) may present with a bulbar-onset motor neuron disease-like phenotype, mimicking bulbar-onset amyotrophic lateral sclerosis. Recognition of their distinctive clinical and ... Trigeminal nerve involvement was assessed using comprehensive clinical, laboratory, electrophysiologic, and MRI workup.... Both patients were referred for progressive dysphagia, sialorrhea, and hoarseness. They were treated with bilevel positive airway pressure for nocturnal hypoventilation. Patient 1 complained of contin... In case of progressive atypical bulbar symptoms, the presence of a trigeminal neuropathy or trigeminal nerve abnormalities on MRI should encourage the testing of IgLON5-Abs in serum and CSF....